These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 25730009)

  • 1. Role of fibroblast growth factor-23 in the pathogenesis of atherosclerosis in peritoneal dialysis patients.
    Zeng Y; Feng S; Han OY; Shen HY; Jin DH; Shi YB
    Genet Mol Res; 2015 Jan; 14(1):719-29. PubMed ID: 25730009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma fibroblast growth factor-23 levels are independently associated with carotid artery atherosclerosis in maintenance hemodialysis patients.
    Balci M; Kirkpantur A; Gulbay M; Gurbuz OA
    Hemodial Int; 2010 Oct; 14(4):425-32. PubMed ID: 20955275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor is associated to left ventricular mass index, anemia and low values of transferrin saturation.
    Eser B; Yayar O; Buyukbakkal M; Erdogan B; Ercan Z; Merhametsiz O; Haspulat A; Oğuz EG; Dogan İ; Canbakan B; Ayli MD
    Nefrologia; 2015; 35(5):465-72. PubMed ID: 26394828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor 23 and left ventricular mass index in maintenance hemodialysis patients: standard versus long nocturnal hemodialysis.
    Knap B; Večerić-Haler Ž; Benedik M; Buturović-Ponikvar J; Ponikvar R; Bren AF
    Ther Apher Dial; 2013 Aug; 17(4):407-11. PubMed ID: 23931880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between fibroblast growth factor 23 and left ventricular hypertrophy in maintenance hemodialysis patients. Comparison with B-type natriuretic peptide and cardiac troponin T.
    Negishi K; Kobayashi M; Ochiai I; Yamazaki Y; Hasegawa H; Yamashita T; Shimizu T; Kasama S; Kurabayashi M
    Circ J; 2010 Nov; 74(12):2734-40. PubMed ID: 21041973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
    Al-Hweish A; Sultan SS; Mogazi K; Elsammak MY
    Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do elevated plasma S100A12 levels predict atherosclerosis in peritoneal dialysis patients?
    Yayar O; Eser B; Buyukbakkal M; Erdogan B; Ercan Z; Merhametsiz O; Haspulat A; Kali A; Yildirim T; Canbakan B; Ayli MD
    Ren Fail; 2015 Jun; 37(5):845-50. PubMed ID: 26016405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monocyte chemoattractant protein-1 (MCP-1) and fibroblast growth factor-21 (FGF-21) as biomarkers of subclinical atherosclerosis in women.
    Basurto L; Gregory MA; Hernández SB; Sánchez-Huerta L; Martínez AD; Manuel-Apolinar L; Avelar FJ; Alonso LAM; Sánchez-Arenas R
    Exp Gerontol; 2019 Sep; 124():110624. PubMed ID: 31152776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of dialysate calcium concentration with fetuin A level and carotid intima-media thickness in peritoneal dialysis patients.
    Liang J; Wang Z; Liu G; Zhan J; Jiang L; Jiang Z
    Ren Fail; 2014 Feb; 36(1):65-8. PubMed ID: 24028708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor-23 levels are associated with uric acid but not carotid intima media thickness in renal transplant recipients.
    Asicioglu E; Kahveci A; Arikan H; Koc M; Tuglular S; Ozener C
    Transplant Proc; 2014; 46(1):180-3. PubMed ID: 24507048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating fibroblast growth factor 23 in children on peritoneal dialysis is associated with effective dialysis.
    Hacıhamdioğlu DÖ; Düzova A; Alehan D; Oğuz B; Beşbaş N
    Turk J Pediatr; 2015; 57(1):9-16. PubMed ID: 26613215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between plasma fibroblast growth factor-23 and subclinical cardiovascular damages in children with primary hypertension].
    Lin Y; Shi L; Liu YY; Zhang HW; Liu Y; Zhang MM; Huang XL; Hou DQ; Cui XD
    Zhonghua Er Ke Za Zhi; 2019 Jun; 57(6):471-476. PubMed ID: 31216806
    [No Abstract]   [Full Text] [Related]  

  • 13. Early markers of cardiovascular risk in chronic kidney disease.
    Lai S; Dimko M; Galani A; Coppola B; Innico G; Frassetti N; Mazzei ED; Mariotti A
    Ren Fail; 2015 Mar; 37(2):254-61. PubMed ID: 25394527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline carotid intima-media thickness is associated with cardiovascular morbidity and mortality in peritoneal dialysis patients.
    Asicioglu E; Velioglu A; Arikan H; Koc M; Tuglular S; Ozener C
    Ther Apher Dial; 2021 Dec; 25(6):962-969. PubMed ID: 33511768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac biomarkers and noninvasive predictors of atherosclerosis in chronic peritoneal dialysis patients.
    Caliskan Y; Ozkok A; Akagun T; Alpay N; Guz G; Polat N; Tufan F; Ecder T; Bozfakioglu S
    Kidney Blood Press Res; 2012; 35(5):340-8. PubMed ID: 22473007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is FGF-23 an early indicator of atherosclerosis and cardiac dysfunction in patients with gestational diabetes?
    Tuzun D; Oguz A; Aydin MN; Kurutas EB; Ercan O; Sahin M; Ünsal V; Ceren I; Akçay A; Gul K
    Arch Endocrinol Metab; 2018 Oct; 62(5):506-513. PubMed ID: 30462803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor-23 and interleukin-6 are risk factors for left ventricular hypertrophy in peritoneal dialysis patients.
    Liu WH; Zhou QL; Ao X; Yu HL; Peng WS; He N
    J Cardiovasc Med (Hagerstown); 2012 Sep; 13(9):565-9. PubMed ID: 22728833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum fibroblast growth factor-23 (FGF-23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients.
    Kirkpantur A; Balci M; Gurbuz OA; Afsar B; Canbakan B; Akdemir R; Ayli MD
    Nephrol Dial Transplant; 2011 Apr; 26(4):1346-54. PubMed ID: 20813767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of cardiovascular risk in paediatric peritoneal dialysis patients: a Turkish Pediatric Peritoneal Dialysis Study Group (TUPEPD) report.
    Bakkaloglu SA; Saygili A; Sever L; Noyan A; Akman S; Ekim M; Aksu N; Doganay B; Yildiz N; Duzova A; Soylu A; Alpay H; Sonmez F; Civilibal M; Erdem S; Kardelen F
    Nephrol Dial Transplant; 2009 Nov; 24(11):3525-32. PubMed ID: 19541662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor 23, but not parathyroid hormone, is associated with urinary phosphate regulation in patients on peritoneal dialysis.
    Yamada S; Tsuruya K; Tokumoto M; Yoshida H; Hasegawa S; Tanaka S; Eriguchi M; Nakano T; Masutani K; Ooboshi H; Kitazono T
    Ther Apher Dial; 2015 Feb; 19(1):73-80. PubMed ID: 25195562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.